1. Hatsukami, D. K., C. Lemmonds, Y. Zhang, et al. Evaluation of carcinogen exposure in people who used “reduced exposure” tobacco products. J Natl Cancer Inst 2004; 96(11): 844–852.
2. Patel, P.S., M. H. Shah, F. P. Jha, et al. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer 2004; 41(1): 25–31.
3. Meckley, D. R., J. R. Hayes, K. R. Van Kampen, P. H. Ayres, A. T. Mosberg, and J. E. Swauger. Comparative study of smoke condensates from 1R4F cigarettes that burn tobacco versus ECLIPSE cigarettes that primarily heat tobacco in the SENCAR mouse dermal tumor promotion assay. Food Chem Toxicol 2004; 42(5): 851–863.
4. Nguyen Van Binh, P., D. Zhou, F. Baudouin, et al. In vitro and in vivo immunotoxic and immunomodulatory effects of nonsupplemented and selenium-supplemented cigarette smoke condensate. Biomed Pharmacother 2004; 58(2): 90–94.
5. West, K. A., I. R. Linnoila, S. A. Belinsky, C. C. Harris, and P. A. Dennis. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3′-kinase/Akt pathway in vitro and in vivo. Cancer Res 2004; 64(2): 446–451.